You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 7, July 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (10)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Colon Cancer
 •Oncology, Other
 •Radiation Therapy
 •Surgery
 •Surgery, Other
 •Review
 •Gastroenterology
 •Gastrointestinal Diseases
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Yttrium 90 Microsphere Selective Internal Radiation Treatment of Hepatic Colorectal Metastases

Seza A. Gulec, MD; Yuman Fong, MD

Arch Surg. 2007;142(7):675-682.

Objective  To discuss the basic concepts involved in the development of yttrium 90 (Y-90) microsphere selective internal radiation treatment and review the clinical data pertaining to its application in hepatic colorectal cancer metastases.

Data Sources  Published studies and scientific paper presentations.

Study Selection  Randomized clinical studies and retrospective reviews.

Conclusions  Selective internal radiation treatment is a promising new modality in the treatment of patients with hepatic colorectal cancer metastases as part of a multimodality approach. A chemo–selective internal radiation treatment neoadjuvant approach has a potential to improve therapeutic outcomes. Clinical studies in neoadjuvant and salvage settings are needed for more concrete outcome data and design of optimal multimodality treatment strategies.


Author Affiliations: Center for Cancer Care at Goshen Health System, Goshen, Indiana (Dr Gulec); and Memorial Sloan Kettering Cancer Center, New York, New York (Dr Fong)



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Yttrium 90 Microsphere Selective Internal Radiation Treatment of Hepatic Colorectal Metastases
Timothy J. Price and Amanda Townsend
Arch Surg. 2008;143(3):313-314.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma
Kim et al.
Ann Oncol 2009;20:780-787.
ABSTRACT | FULL TEXT  

Yttrium 90 Microsphere Selective Internal Radiation Treatment of Hepatic Colorectal Metastases
Price and Townsend
Arch Surg 2008;143:313-314.
FULL TEXT  

Posttherapy Radiation Safety Considerations in Radiomicrosphere Treatment with 90Y-Microspheres
Gulec and Siegel
JNM 2007;48:2080-2086.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.